Novel Agent, Sacubitril-Valsartan: Prescribing Patterns and Perceived Barriers to Hospital Formulary Inclusion

Clinical Studies & Medical Case Reports
doi 10.24966/csmc-8801/100062
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Herald Scholarly Open Access

Related search

Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Potential Markers of Sacubitril-Valsartan Tolerance

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Sacubitril/Valsartan Use for the Hospitalist

American Journal of Hospital Medicine
2017English

Sacubitril/Valsartan: Beyond Natriuretic Peptides

Heart
Cardiovascular MedicineCardiology
2017English

Evaluating the Safety and Tolerability of Inpatient Sacubitril/Valsartan Initiation in a Community Hospital

Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
2020English

Study on Child Perceived Barriers to School Inclusion in Telangana

ADVANCE RESEARCH JOURNAL OF SOCIAL SCIENCE
2016English

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Sacubitril/Valsartan Verbessern Auch Den HbA1c-Wert

MMW Fortschritte der Medizin
Medicine
2017English

Pcv44 - Effectiveness of Sacubitril/Valsartan Versus Enalapril in Reducing Mortality and Hospitalizations Costs From a Moroccan Hospital Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy